ABBV · 8-K · 20261030PR000033
Operating Income and Margins
AbbVie Inc. · 2026-10-30 · Importance 61 · Surprise 46 · From source text
Third-quarter operating earnings were $6.267 billion, compared with $1.904 billion in the prior-year quarter. GAAP operating margin was 36.0%, while adjusted operating margin was 48.7%. Total operating costs and expenses declined to $11.137 billion from $13.872 billion, including acquired IPR&D and milestones expense of $216 million versus $2.680 billion in the prior-year quarter.
Key facts
- Third-quarter 2026 operating earnings were $6.267 billion, compared with $1.904 billion in Q3 2025. source
- Third-quarter 2026 GAAP operating margin ratio was 36.0%, and adjusted operating margin ratio was 48.7%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | realized | +25.7% | Third-quarter 2026 operating earnings were $6.267 billion, compared with $1.904 billion in Q3 2025. |